About
Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GSK in 2013. APVC invests globally and takes a handson role on the boards of startups advancing bioelectronic medicines and their enabling technologies. The firm is committed to fostering an inclusive and diverse workspace, contributing to a more equitable healthcare investor and entrepreneurial community. APVC's investment team expressly extends this commitment to the companies They invest in. APVC backs teams developing innovative medical and health tech solutions, focusing on transformative therapies and technologies aimed at improving patient outcomes.